Tech Company Financing Transactions
LTS Lohmann Therapie-Systeme AG Funding Round
LTS Lohmann Therapie-Systeme AG closed a $4.3 million funding round on 12/19/2023. Investors included Bill & Melinda Gates Foundation.
Transaction Overview
Company Name
Announced On
12/19/2023
Transaction Type
Venture Equity
Amount
$4,300,000
Round
Undisclosed
Investors
Bill & Melinda Gates Foundation (Lead Investor)
Proceeds Purpose
The purpose of the grant is to support the development of microneedle array patches (MAP) for self-administration of contraceptives for women in low- and middle-income countries (LMICs). The grant will fund $4.3 million over a duration of 25 months.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Lohmannstraße 2
Andernach, D-56626
Germany
Andernach, D-56626
Germany
Phone
Website
Email Address
Overview
Manufacturer of transdermal systems and oral thin films intended to serve the pharmaceutical industry. The company specializes in developing and manufacturing drug delivery systems by researching complementary micro-array patches for the transdermal delivery of large molecule, biological actives, enabling doctors to offer their patients reliable and safe therapeutic efficacy.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sebastiaan M. van Buijtenen
Chief Financial Officer
Ulrich Sielaff
Chief Operating Officer
B. Michael Hoffmann
Browse more venture capital transactions:
Prev: 12/19/2023: ScaleOps venture capital transaction
Next: 12/19/2023: Netris Pharma venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs